However, treatment with Dabrafenib significantly decreased the tumor burden (Figure 7I–K), extended the overall survival of animals bearing NHA/HRasV12/TRIM24 brain tumor xenografts (P < 0.01) (Figure 7L), and reduced tumor Ki‐67 and ATF3 protein expression (Figure 7M,N). This evidence concerns the gene ATF3 and neoplasm.